$XON News Article - Precigen Announces First Patie
Post# of 8
(Total Views: 375)
Posted On: 06/26/2019 1:20:44 PM
$XON News Article - Precigen Announces First Patient Dosed in Phase 1/1b Study of PRGN-3006 UltraCAR-T(TM) in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Higher Risk Myelodysplastic Syndrome (MDS) https://marketwirenews.com/news-releases/prec...16822.html
(0)
(0)Precigen, Inc. (PGEN) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼